{"id":101232,"title":"Poolbeg Pharma PLC (AIM:POLB) to attend HC Wainwright Global Investment Conference, New York City, USA","publisher":"Share Talk","author":"sharetalk","published":"2022-09-12T06:54:05+00:00","modified":"2022-09-12T06:54:05+00:00","canonical_url":"https://www.share-talk.com/poolbeg-pharma-plc-aimpolb-to-attend-hc-wainwright-global-investment-conference-new-york-city-usa/","markdown_url":"https://www.share-talk.com/poolbeg-pharma-plc-aimpolb-to-attend-hc-wainwright-global-investment-conference-new-york-city-usa.md","json_url":"https://www.share-talk.com/poolbeg-pharma-plc-aimpolb-to-attend-hc-wainwright-global-investment-conference-new-york-city-usa.json","category":"Healthcare","categories":["Healthcare","Pharmaceutical"],"tags":["Cathal Friel","immunomodulator","Influenza","Jeremy Skillington","molecule","New York City","NY","Open Orphan","ORPH","POLB","Poolbeg Pharma","respiratory","Share Talk","Syncytial","US Patent","USA","virus"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&ssl=1","format":"news","language":"en-GB","content":"12 September 2022 – **Poolbeg Pharma** (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model.\n\nAnnounces that the Company’s Chairman, Cathal Friel, will be attending the HC Wainwright Global Investment Conference, which is taking place from 12-14 September at the Lotte New York Palace Hotel in New York City, NY, USA.\n\n– Ends –\n\nEnquiries\n\n**Poolbeg Pharma Plc**\n\n**Jeremy Skillington, CEO**\n\n**Ian O’Connell, CFO**\n\n**+44 (0) 20 7183 1499**"}